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Summary  Nocardia  asteroides  is  a  rare  pathogen  in  peritoneal  dialysis-related
peritonitis.  We  report  on  a 13-year-old  female  with  Nocardia  asteroides  peri-
tonitis  complicated  by  an  intra-abdominal  abscess.  Linezolid  was  administered
intravenously  for  3  months  and  followed  by  oral  therapy  for  an  additional  5  months
with  close  monitoring  for  adverse  effects.  The  patient  was  discharged  after  3  months
of  hospitalization  on  hemodialysis.  The  diagnosis  and  management  of  such  cases  can
be  problematic  due  to  the  slow  growth  and  difﬁculty  of  identifying  Nocardia  species.
The  optimal  duration  of  treatment  for  Nocardia  peritonitis  is  not  known.  LinezolidOman
can  be  used  for  prolonged  periods  in  cases  of  trimethoprim/sulfamethoxazole-
resistant  cases  with  close  monitoring  for  adverse  effects.
©  2015  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Limited.  All  rights  reserved.∗ Corresponding author at: Sultan Qaboos University, Child
Health Department, PO Box 35, Al-Khod 123, Oman.
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eritoneal  dialysis  (PD)  is a  widely  used  modal-
ty for  renal  replacement  therapy.  Peritonitis  is  a
ommon problem  in  patients  undergoing  continuous
mbulatory  peritoneal  dialysis  (CAPD)  and  repre-
ents the  most  frequent  cause  of  hospitalization
nces. Published by Elsevier Limited. All rights reserved.
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wocardia  asteroides  peritoneal  dialysis-related  peri
eritoneal  catheter  loss,  technique  failure,  dis-
ontinuation  of  CAPD,  and  mortality  are  exhibited
y these  patients.  Staphylococcus  species  are  usu-
lly implicated  in  infectious  cases  of  peritonitis  in
atients  undergoing  CAPD.  Fungi  and  higher  bacte-
ia such  as  Nocardia  asteroides  are  less  frequent
ausative agents  [1].
Nocardiosis  was  named  after  the  French  veteri-
arian Edmond  Nocard  in  the  late  1800s  and  is  an
nfection  caused  by  gram-positive  aerobic  bacteria
f the  genus  Nocardia  [2]. Despite  its  universal  pres-
nce in  soil,  organic  matter  and  water,  Nocardia  is  a
are pathogen  of  PD-related  peritonitis  [2].  Human
nfections  are  primarily  observed  in  immunocom-
romised hosts  and  typically  originate  in  the  lungs
nd then  spread  to  other  organ  systems,  including
he brain,  skin  and  kidney  [4].
Linezolid is a  synthetic  oxazolidinone,  which  is
 novel  class  of  antibiotics  with  clinical  utility  in
he treatment  of  infections  caused  by  gram-positive
erobic bacteria.  Linezolid  binds  to  a  site  on  the
acterial  23S  ribosomal  RNA  of  the  50S  subunit  to
revent  the  formation  of  a  functional  70S  initia-
ion complex,  which  is  an  essential  component  of
he bacterial  translation  process.  Linezolid  is  pri-
arily indicated  for  the  treatment  of  infections
aused by  resistant  gram-positive  organisms  partic-
larly methicillin-resistant  Staphylococcus  aureus
nd vancomycin-resistant  Enterococcus  species.
inezolid  also  exhibits  in  vitro  activities  against
ome gram-negative  anaerobes  and  mycobacterial
pecies, including  Mycobacterium  tuberculosis  and
ocardia spp.  [5—7]. Here,  we  report  the  ﬁrst  case
f Nocardia  asteroides  peritonitis  in  a  pediatric
atient who  was  treated  with  a  protracted  course
f linezolid.
ase report
 13-year-old  female  had  been  receiving  CAPD
or 3  years  due  to  diffuse  global  sclerosis  com-
licated by  end-stage  renal  failure.  She  also  had
amilial  leukodystrophy  with  cerebellar  ataxia  and
yramidal  features.  She  presented  with  high-grade
ever, leakage  from  the  exit  site  of  the  perit-
neal catheter,  and  diffuse  abdominal  pain  for  7
ays. She  was  admitted  with  a  suspected  catheter
xit-site  or  tunnel  infection  complicated  by
eritonitis.
On presentation,  she  was  lethargic,  tachypneic
40—45 breaths/min)  with  no  respiratory  distress,
achycardic (heart  rate  125—135  beats/min),  with
 temperature  of  40.2 ◦C.  Her  weight  was  18  kg
below the  3rd  percentile  for  age  and  sex).  Physical
xaminations were  all  within  normal  limits  except
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or  generalized,  mild  abdominal  tenderness  and
eurological  ﬁndings  consistent  with  the  primary
isease. The  exit  site  exhibited  no  inﬂammation,
ut there  was  marked  dialysate  leakage.  The  lab-
ratory data  revealed  the  following:  white  cell
ount  10,300/mm3, hemoglobin  5.9  g/dL,  platelets
05,000/mm3, C-reactive  protein  146  mg/L,  albu-
in 24  g/L,  ALT  15  U/L,  AST  24  U/L,  Na  125  mmol/L,
 3.6  mmol/L,  bicarbonate  17  mmol/L,  creatinine
47 mol/L,  and  urea  20.9  mmol/L.  The  dialysate
as turbid  with  white  sediment,  and  the  leukocyte
ount 300/mm3 (neutrophils  90%  and  lymphocytes
0%). Gram-stain  of the  dialysate  revealed  gram-
ositive  bacilli,  and  a modiﬁed  Kinyoun  stain
evealed partially  acid-fast  branching  bacilli.  In
lood agar,  the  colonies  exhibited  a  chalky  white,
otton  candy  appearance  with  reductus  on  the  sur-
ace, which  denoted  Nocardia  species.  The  isolate
as ultimately  identiﬁed  as  Nocardia  species  after
 weeks  of  incubation.
The running  peritoneal  dialysis  prescription  was
or Bicavera  peritoneal  ﬂuid  at  a  1000-ml  volume,
0-min  input,  indwelling  time  of  4  hr  and  an  output
f 20  min.  We  used  an  alternating  cycle  of  1.5%  and
.3% for  a  total  of 5  cycles.  We  used  rapid  cycles
n and  out  with  no  rest  indwelling  time  until  the
uid was  clear  because  the  ﬂuid  was  still  turbid  and
ull of  sediment.  Next,  we  initiated  a 1.5-h  cycle
10 min  input  with  an  indwelling  time  1 hr  and  out  at
0 min)  with  a  small  volume  of  600  ml  1.5%  glucose.
 short-cycle  regimen  and  small  ﬁll  volume  were
sed for  more  efﬁcient  dialysis  and  to  decrease
he dialysate  leakage.  The  patient  was  initiated
n intraperitoneal  vancomycin,  ciproﬂoxacin  and
ntravenous  (IV)  cloxacillin.  Amphotericin-B  was
dded after  4  days  due  to  suspected  fungal  peritoni-
is. Because  no  clinical  improvement  was  observed,
iproﬂoxacin  was  replaced  with  intraperitoneal  cef-
azidime, the  IV  cloxacillin  was  stopped,  and  IV
eropenem  and  amikacin  were  added.  The  child
ent into  cardiac  arrest  and  septic  shock  after
0 days  of  conservative  management  with  the  dif-
erent antibiotic  regimens.  A  peritoneal  culture
rew Nocardia  asteroides  after  2  weeks  that  exhib-
ted sensitivity  to  linezolid,  imipenem  and  amikacin
nd resistance  to  trimethoprim-sulfamethoxazole.
epeated  blood  culture  revealed  no  growth  with
o isolation  of  organisms  even  after  a  prolonged
ncubation period.
The  catheter  was  removed,  and  the  child  was
anaged in  the  pediatric  intensive  care  unit
ith continuous  venovenous  hemoﬁltration  (CVVH),
echanical  ventilation  and  inotropic  support.  CVVH
as performed  because  the  child  was  very  sick,  and
onventional  pediatric  hemodialysis  is  not  avail-
ble in  our  institute.  The  case  was  complicated
194  M.  El-Naggari  et  al.
Figure  1  Abdominal  U/S  revealing  an  abscess  in  lower
abdomen  in  the  left  iliac  fossa.
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gFigure  2  CT-ABD:  sagittal  section  revealing  lower  left
iliac  abscess.
by  a  peritoneal  abscess  following  the  removal
of the  catheter.  Abdominal  ultrasound  revealed
an intraabdominally  localized  collection  that  was
evacuated  by  ultrasound-guided  aspiration  (Fig.  1).
Jejunal adhesions  with  some  feeding  intolerance
were treated  conservatively  (Figs.  2  and  3).
Linezolid was  commenced  based  on  drug  sensi-
tivity ﬁndings  and  the  critical  clinical  situation  of
the child  despite  the  cost,  the  paucity  of  literature
o
t
i
tigure  3  CT-ABD:  cross-section  revealing  a  lower  left
liac  abscess  with  free  intra-abdominal  collection.
n  linezolid  in  other  Nocardia  infections,  and  the
act that  it  had  never  been  used  for  Nocardia  peri-
onitis. The  guardian  consented  to  the  use  linezolid
fter counseling  regarding  these  issues.  Linezolid
as intravenously  administered  (10  mg/kg  BID)  for  3
onths in  the  hospital.  Good  clinical  improvement
as observed,  and  weaning  and  extubation  were
uccessfully  performed.  The  patient  was  closely
onitored for  treatment-related  adverse  effects,
ncluding  myelosuppression.  Hematological  abnor-
alities in  the  forms  of  anemia,  thrombocytopenia
nd leucopenia  are  early  side  effects  that  have
een reported  with  linezolid  therapy.  Serial  full
lood  counts  were  performed  and  found  to  be
ormal. The  patient  was  discharged  home  after
 months  of  hospitalization  and  rehabilitation  on
emodialysis  and  tolerated  oral  and  small  bowel
eeding.  Linezolid  oral  therapy  (10  mg/kg  BID)  was
ontinued  for  5  months,  and  no  side  effects  were
eported. A  prolonged  duration  of  treatment  with
inezolid  was  anticipated  given  that  Nocardia  infec-
ion has  a  high  incidence  of  recurrence.
iscussion
ocardia  is  an  uncommon  cause  of  PD-related  peri-
onitis. The  species  of  the  genus  Nocardia  are
ram-positive  branching  bacteria  that  belong  to  the
rder Actinomycetales.  These  bacteria  are  ubiqui-
ous in  the  environment  and  are  found  in  the  soil,
n fresh  and  salt  water,  and  in  decaying  vegeta-
ion. Most  Nocardia  infections  in  humans  are  caused
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Table  1  Summary  of  previous  reports  of  Nocardia  CAPD  peritonitis.
Author  (year)
(Ref.)
Age  Sex  Cause  of
ESRD
Organism  Incubation
period
CAPD
duration
(years)
Previous
peritonitis
event(s)
Medical  treatment  Catheter
removal
Arfania  et  al.  [3]  70  M  CIN  N.
asteroides
—  1  1  IP  sulﬁsoxazole  6  weeks  No
Chan  et  al.  [10]  60  M  PCKD  Nocardia
spp.
5  Weeks  5  2  IP  TMP-SMX  3  weeks  No
Kaczmarski  et  al.
[11]
58  F  NA  N.asteroides  6  days  2  10  IP/IV  ceftazidime  +  netilmicin
2  weeks
Yes
Lopes  et  al.  [12] 38  M  SLE  N.
asteroides
7  days  6  2  IP  TMP-SMX  4  weeks  No
Recule  et  al.  [13] 80  M  NA  Nocardia
nova
4  days  1.5  3  After  removal  of
catheter,oral  TMP-SMX  3
weeks
Yes
Dwyer  et  al.  [14] 32  M  Type  1  DM Nocardia
nova
1 week 6  6  1  week  antibiotic  Yesa
Chu  et  al.  [15] 68  F  NA  Nocardia
spp.
4 days 4  0  IP  TMP-SMX  +  IV  ceftriaxone  2
weeks
Nob
Ortiz  et  al.* [16]  35  M  CBUS  N.
asteroides
—  2.5  0  IV  TMP-SMX  +  IP  Amikacin  5
weeks,  Oral  Cefruxime  +  IP
Amikacin  12  weeks.
No
Li  et  al.  [17]  75  M  Type  2  DM  Nocardia
spp.
2 weeks  1  0  Oral  TMP-SMX  4  weeks,  IP
TMP-SMX  3  weeks
Yes
Jones  et  al.  [18]  66  M  Type  2  DM  N.
asteroides
3 weeks  3  1  IP  cephazolin  and
gentamicin,  Oral  TMP-SMX
Yes
Prasad  et  al.  [19]  52  M  Type  2  DM  N.
asteroides
—  1.5  2  IP  TMP-SMX  4  Days,  IV
Ceftriaxone  +  Ciproﬂoxacin  2
weeks
Yesc
Current  case  12  F  DGS  N.
asteroides
2 weeks  3  1  IP  van-
comycin  +  cipro/ceftazidime
2  wk,  IV  linezolid  3  M,  oral  5  M
Yesd
CAPD = continuous ambulatory peritoneal dialysis; ESRD = end-stage renal disease; CIN = chronic interstitial nephropathy; PCKD = polycystic kidney disease; NA = not available;
SLE = systemic lupus erythematous; DM = diabetes mellitus; Rx = prescription; IP = intraperitoneal; TMP-SMX = trimethoprim-sulphamethoxazole; IV = intravenous; CBUS = congenital bilat-
eral ureteral stenosis; DGS= diffuse global sclerosis.
a Intra-abdominal abscess occurred 10 days after catheter removal, requiring surgical drainage and 4 months of IV imipenem treatment.
b Died of myocardial infarction before IP antibiotic treatment was complete.
c Died of relapsing peritonitis after 2 weeks of admission, associated with Nocardia pneumonia.
d Complicated with intra-abdominal abscess that need drainage.
* APD = Automated Peritoneal Dialysis.
Rubin et al. [20] reported one case of Nocardia peritonitis in CAPD patient.
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by  N.  asteroides, N.  nova,  N.  farcinica,  and  N.
brasiliensis. The  majority  of  patients  with  clinically
recognized  disease  have  underlying  predisposing
factors [4].  Our  patient  had  potential  environmen-
tal exposure  through  her  rural  lifestyle,  and  we
speculate  that  contaminated  soil  or  water  contain-
ing Nocardia  was  introduced  into  the  peritoneum
via her  PD  catheter  or  she  had  a  tunnel  infection  due
to touch  contamination.  Unusual  organisms  must  be
considered  when  PD  peritonitis  is  culture-negative
or refractory  to  standard  antibiotic  treatment.
To the  best  of  our  knowledge,  there  are  10  case
reports of  Nocardia  CAPD  peritonitis  and  only  one
case report  of  a  patient  on  automated  PD  in  the
literature (Table  1).  Decisions  regarding  catheter
removal  appear  to  be  crucial  in  the  management
of peritonitis.  Successful  treatment  of  Nocardia
peritonitis has  been  reported  with  and  without
PD catheter  removal.  The  catheters  have  been
removed in  ﬁve  of  the  11  patient  cases  reported
thus far.
Moylett  et  al.  [5]  reported  six  cases  of  Nocardia
treated with  linezolid,  and  all  of  these  cases  were
cured.  Linezolid  was  used  as  monotherapy  in  four
of these  cases.  Two  pediatric  cases  at  ages  of  6 and
9 years  were  diagnosed  as  chronic  granulomatous
disease with  pneumonia  and  disseminated  Nocar-
dia, respectively.  Linezolid  was  used  for  24  months
in the  ﬁrst  and  12  months  in  the  second  case  with
complete  cure  and  no  reported  adverse  effects.
Therefore, linezolid  therefore  appears  to  be  an
effective  alternative  for  the  treatment  of  nocar-
diosis. Shen  et  al.  [7]  reported  14  cases  of  Nocardia
that were  treated  with  linezolid,  and  13  cases  were
conﬁrmed  to  have  achieved  clinical  cure.
In an  evaluation  of  linezolid  treatment  in  447
children, Chiappini  et  al.  [8]  reported  variable  clin-
ical cure  rates  ranging  from  77.5%  to  90.0%  in
children with  bacteremia  or  pneumonia.  The  most
frequently  reported  adverse  events  were  diarrhea
(incidence  3.1—16.8%),  nausea  and/or  vomiting
(2.9—11.9%), and  thrombocytopenia  (1.9—4.7%).
To date,  three  cases  of  neuropathy  have  been
described in  children.
Garazzino  et  al.  [9]  studied  the  clinical  experi-
ence of  linezolid  use  in  infants  and  children  (611
children  in  four  clinical  trials  and  206  children  in
case reports  and  case  series  aged  up  to  17  years).
Thrombocytopenia  occurred  in  1.9%  of  the  patients,
anemia  in  1.4%  of  the  patients,  and  neutropenia  in
none of  the  patients.  Four  cases  of  peripheral  and
optic neuropathy  in  children  have  been  reported
thus far.  Nocardia  infection  generally  presents  as
an infection  that  is  unresponsive  to  empirical  treat-
ment and  initially  appears  as  ‘culture-negative’
peritonitis.  The  diagnosis  and  management  ofM.  El-Naggari  et  al.
ocardia  infection  can  be  problematic  due  to  the
low growth  and  difﬁcult  identiﬁcation  of  Nocardia
pecies. The  choice  of  therapy  should  be  deter-
ined based  on  local  sensitivity  patterns.  Linezolid
as used  in  this  study  because  there  was  no  alter-
ative  agent;  linezolid  can  be  used  in  the  pediatric
ge group  over  the  long-term  without  side  effects
f monitoring  is  performed.  Additionally,  long-term
reatment  with  linezolid  requires  at  least  one  year
f no  complications  are  observed.
onclusion
e  report  the  ﬁrst  case  of  Nocardia  asteroides
eritonitis in  a pediatric  subject  who  was  success-
ully treated  with  the  administration  of  linezolid
or eight  months  under  monitoring  without  any  side
ffects. Catheter  removal  and  shifting  to  hemodial-
sis should  be  considered  for  patients  who  do  not
espond  to  intraperitoneal  antibiotics.
The optimal  duration  of  treatment  for  Nocar-
ia peritonitis  is not  known;  however,  a prolonged
reatment course  is  necessary  due  to  the  occur-
ence of  a  considerable  number  of  relapses
ollowing shorter  courses  of  therapy.  Linezolid  can
e used  in  pediatric  patients  for  prolonged  periods
n trimethoprim/sulfamethoxazole-resistant  cases
ith close  monitoring  for  adverse  effects.
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